Puma Biotech (PBYI) Reports Q2 Loss of $1.13

Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.13), versus ($1.05) reported last year.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform